The medical world is observing a remarkable shift in blood sugar treatment with the arrival of GLP-1 transdermal devices. These patches offer a possibly more convenient alternative to shots of GLP-1 receptor agonists, reducing the need for daily needle pricks. The technology delivers the medication directly through the epidermis, potentially improv